BRS3 - Inflammation & Oxidative Stress
(Immune Signalling, Antioxidant Defence & Inflammatory Control)
Maintains anti-inflammatory signalling tone by regulating cytokine activity, NF-κB-linked inflammatory drive, and gut-derived immune inputs.
FM page: BRS3(FM1) — Anti-Inflammatory Signalling Tone
Primary biological effects: ↓ NF-kB tone; ↓ pro-inflammatory cytokines; ↑ immune signalling balance
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Daily
Key constraints:
Connected mechanisms:
- BRS3-FM2-PM3 - Nrf2-Mediated Cellular Defence Regulation — Nrf2-Mediated Cellular Defence Regulation
- BRS3-FM2-PM4 - ROS Generation vs Clearance Balance — rOS Generation vs Clearance Balance
- BRS3-FM3-PM7 - Cytokine Network Modulation — cytokine Network Modulation
- BRS5-FM1-PM1 — Gut Barrier / Tight Junction Integrity — gut Barrier / Tight Junction Integrity
- BRS5(FM1) — Gut Barrier Integrity and Immune Interface — Upstream NF-κB transcriptional control
- BRS6-FM1-PM2 — Glycaemic Variability Regulation — Insulin Sensitivity & Glucose Disposal
- BRS3-FM2-PM3 — Nrf2-Mediated Cellular Defence Regulation
- BRS3-FM2-PM4 — ROS Generation vs Clearance Balance
- BRS3-FM2-PM5 — Lipid Peroxidation Control
- BRS3-FM2-PM6 — Antioxidant Network Recycling
Maintains antioxidant defense capacity by coordinating endogenous and dietary protection against redox overload and lipid peroxidation.
FM page: BRS3(FM2) — Antioxidant Defense Capacity
Primary biological effects: ↑ antioxidant enzyme induction; ↑ ROS buffering; ↓ oxidative damage
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Daily
Key constraints:
Connected mechanisms:
- BRS3-FM3-PM8 - Eicosanoid / SPM Balance — eicosanoid / SPM Balance
- BRS3(FM1) — Anti-Inflammatory Signalling Tone — anti-Inflammatory Signalling Tone
- BRS4-FM1-PM1 — Electron Transport Chain Function — electron Transport Chain Function
- BRS4-FM2-PM4 — ROS Production and Control — biological connection relevant to this mechanism
Maintains inflammation-resolution capacity through pro-resolving lipid mediator pathways that actively terminate inflammatory responses.
FM page: BRS3(FM3) — Inflammation Resolution Capacity
Primary biological effects: ↑ resolvins/protectins/maresins; ↑ debris clearance; ↓ unresolved inflammation
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: 48hours
Connected mechanisms:
- BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation — membrane long-chain PUFA substrate pools feeding specialized pro-resolving mediator formation
- BRS3-FM1-PM1 - NF-kB Signalling Regulation — nF-kB Signalling Regulation
- BRS3-FM1-PM2 - Gut-Derived Inflammatory Signalling — gut-Derived Inflammatory Signalling
- BRS3-FM2-PM5 - Lipid Peroxidation Control — lipid Peroxidation Control
- BRS5-FM1-PM2 — LPS / Endotoxin Containment — gut endotoxin containment upstream of systemic cytokine network tone
- BRS5(FM1) — Gut Barrier Integrity and Immune Interface — gut–immune interface context influencing inflammatory resolution substrate availability
- BRS6(FM1) — Glycaemic–Insulin Stability & Cognitive Energy Availability — post-prandial glycaemic context conditioning inflammatory cytokine expression
Ambition
Maintain proportionate immune signalling, responsive antioxidant defence, and active inflammation resolution so the brain operates within a redox and immune environment that supports function rather than chronically constraining it.
Rationale for inclusion as a distinct BRS
Inflammatory and oxidative regulation was defined as a distinct BRS because it coordinates immune signalling tone, antioxidant defence and active resolution of inflammation as a shared operating environment for other systems. Cytokine networks, reactive-oxygen handling and resolution chemistry can divert tryptophan into kynurenine metabolism, alter receptor and membrane conditions, and impose redox load on mitochondria and synapses. BRS3 is therefore represented as an environmental constraint system: its state can modify neurotransmitter regulation and bioenergetic recovery without itself being a transmitter or energy pathway. It is not presented as a universal inflammatory explanation for brain-related conditions, but as a coherent, diet-responsive immune–redox system with biologically traceable dependencies across the wider regulatory network.
Therapeutic Area Research
ADHD is the first fully mapped therapeutic area within the BRAIN Framework, providing a proof of concept for an adaptive biological architecture linking nutrition, biology and function. The same framework is designed to expand across additional therapeutic areas through the shared Phenome Registry.
Introduction
Immune and oxidative biology in ADHD is distributed across gut signalling, cytokine tone, redox balance and resolution capacity — not reducible to a single biomarker. Dietary pattern, omega-3 status, antioxidant sufficiency, food preparation and contaminant exposure all shape whether these capacities stay proportionate under sustained attention demand.
Gut-barrier context and post-meal inflammatory patterns add further load when microbial signalling, eicosanoid balance or antioxidant recycling are already strained — so interpretation must follow connected inflammatory and redox biology rather than isolated lab findings alone.
ADHD: Inflammation & Oxidative Stress Context
ADHD cohorts show overlapping inflammatory and redox signatures: mixed peripheral cytokine and cortisol patterns, gut-microbiome differences, postprandial inflammatory patterns, and oxidative-stress indices consistent with greater net burden rather than a simple antioxidant deficit alone. Adult studies report higher lipid peroxidation and shifted thiol/disulfide homeostasis; child and adolescent cohorts also report elevated oxidative-stress indices; some antioxidant markers may appear normal or compensatorily elevated.
Exposure patterns also matter: ultra-processed foods, metals in additives, Western dietary patterns low in plant fibre, and emerging contaminant burdens may increase exogenous oxidative load alongside gut-immune signalling strain. These findings do not define a universal inflammatory or redox model of ADHD, but they support BRS3 as a relevant biological context for diet-actionable interpretation.
ADHD evidence and connected BRS3 mechanisms
| Evidence | Citation | Connected mechanisms |
|---|---|---|
| Higher hs-CRP and IL-6, with lower TNF-α, BDNF and bedtime salivary cortisol, in children and adolescents with ADHD (mixed marker pattern, not a uniform pro-inflammatory cytokine profile) | Chang et al., 2020 | BRS3-FM3-PM7 |
| Reduced microbiome alpha diversity reported in ADHD | Prehn-Kristensen et al., 2018 | BRS3-FM1-PM2, BRS5(FM1) |
| Significantly higher malondialdehyde in adult ADHD versus controls | Bulut et al., 2007 | BRS3-FM2-PM4, BRS3-FM2-PM5 |
| Thiol/disulfide homeostasis shifted toward oxidation and higher leukocyte 8-OHdG in adult ADHD | Kurhan & Alp, 2021 | BRS3-FM2-PM4 |
| Elevated oxidative stress index and total oxidative status in children and adolescents with ADHD | Miniksar et al., 2023 | BRS3-FM2-PM4 |
| Narrative review framing a rationale for dietary antioxidant treatment of ADHD via immune, epigenetic, and oxidative-stress hypotheses | Verlaet et al., 2018 | BRS3-FM2-PM3 |
| Elevated glutathione in ADHD may reflect compensatory response to increased oxidative stress | Verlaet et al., 2019 | BRS3-FM2-PM4 |
| ADHD linked with metals contamination and ultra-processed foods, including colour-additive metals | Dufault et al., 2024 | BRS3(FM2), BRS3-FM2-PM4 |
| A small randomized placebo-controlled trial found that Pycnogenol improved attention and reduced hyperactivity in children with ADHD. Companion studies from the same cohort reported normalization of total antioxidant status (TAS), improved glutathione balance, and reduced oxidative DNA damage, providing mechanistic support for oxidative stress pathways in ADHD. Replication remains limited. | Trebatická et al., 2006; Dvořáková et al., 2006; Chovanová et al., 2006 | BRS3(FM2), BRS3-FM2-PM4, BRS3-FM2-PM6 |
Dietary and Lifestyle Levers
Inflammatory and oxidative resilience are built across dietary patterns and recovery, not by antioxidants in isolation. Shared antioxidant substrate pools, dietary patterns and lifestyle collectively determine how effectively inflammatory regulation, redox balance and endogenous defence systems can adapt to changing physiological demands.
The following dietary guidance summarises the principal dietary patterns, shared nutrient pools and representative food sources that support the biological constraints underlying BRS3. The guidance reflects shared biological principles rather than prescriptive recommendations; individual requirements and optimal dietary patterns will vary according to physiology, health status and the wider diet.
Pattern → Nutrients → Biology → Target Foods
Key Constraints of BRS3
Antioxidant Substrates — KC1: Antioxidant Substrate Sufficiency
Centre meals on colourful vegetables, fruits and herbs → polyphenols and vitamin C → immune and redox systems depend on continuous dietary antioxidant input; when plant-derived protective compounds are scarce, inflammatory signalling becomes harder to restrain and ROS clearance capacity declines.
Target foods: Blueberries • Bell Peppers • Oranges • Spinach • Cocoa. KC: BRS3(KC1). BRS: BRS3-FM1-PM1 BRS3-FM2-PM3 BRS3-FM2-PM4 BRS3-FM2-PM6
Distribute quality protein across meals → cysteine, glycine and glutamate → glutathione synthesis depends on these precursor amino acids; sparse or low-quality protein leaves endogenous antioxidant capacity under-supported.
Target foods: Eggs • Chicken • Lentils • Soy • Turkey. KC: BRS3(KC1). BRS: BRS3-FM2-PM4 BRS3-FM2-PM5 BRS3-FM2-PM6
Additional Mechanism-Specific Dietary Levers
Include omega-3-rich foods regularly → EPA, DHA and ALA → long-chain omega-3 status shapes eicosanoid balance and supports specialised pro-resolving mediator formation when inflammatory responses need to terminate.
Target foods: Salmon • Mackerel • Algae • Walnuts • Flax Seeds. BRS: BRS3-FM3-PM8 BRS3-FM2-PM5
Omega-3: Marine foods and algae provide preformed DHA and EPA. Walnuts and flax provide ALA, which requires endogenous conversion to DHA and EPA with variable efficiency.
Include sulphur-rich cruciferous vegetables regularly → glucosinolate-derived compounds → supports NRF2-mediated antioxidant gene activation and endogenous redox defence capacity when cruciferous intake is low.
Target foods: Broccoli • Brussels Sprouts • Cabbage • Kale • Cauliflower. BRS: BRS3-FM2-PM3
Maintain antioxidant-network cofactors through varied whole foods → vitamins C and E, selenium and magnesium → provides the recycling cofactors required for glutathione metabolism and sustained ROS clearance; narrow dietary variety leaves network recycling under-supported.
Target foods: Spinach • Pumpkin Seeds • Eggs • Sardines • Almonds. BRS: BRS3-FM2-PM4 BRS3-FM2-PM6
Include fermentable fibre from whole grains and legumes → soluble fibre and resistant starch → supports microbial fermentation and gut-derived immune signalling that helps modulate systemic inflammatory tone.
Target foods: Barley • Lentils • Oats • Chickpeas • Black Beans. BRS: BRS3-FM1-PM2
Favour extra virgin olive oil as a primary dietary fat → monounsaturated fat and polyphenols → supports lipid peroxidation control and a more resolution-supportive fatty-acid environment alongside antioxidant intake.
Target foods: Extra Virgin Olive Oil. BRS: BRS3-FM2-PM5 BRS3-FM1-PM1
Targeted interventions that may enhance biological system performance beyond foundational dietary guidance and lifestyle priorities. They complement — rather than replace — Key Constraints, Dietary Guidance and Lifestyle Priorities.
Optimising food structure, cooking, bioavailability and nutrient delivery.
Choose gentler cooking methods and avoid repeatedly heating unstable oils to limit lipid oxidation and dietary ROS that can overwhelm antioxidant clearance and lipid peroxidation control.
Supports: BRS3-FM2-PM4 BRS3-FM2-PM5 BRS3-FM1-PM1
Prepare antioxidant-rich vegetables to preserve heat-sensitive compounds to retain vitamin C and polyphenols that support NRF2 activation and sustained ROS clearance rather than losing them to overcooking.
Supports: BRS3-FM2-PM3 BRS3-FM2-PM6
Prepare cruciferous vegetables to retain myrosinase-linked activity to support sulforaphane yield that feeds NRF2-linked antioxidant defence chemistry.
Supports: BRS3-FM2-PM3 BRS3-FM2-PM5 BRS3-FM2-PM6
Soak or sprout phytate-rich seeds and legumes when mineral density matters to improve plant mineral bioavailability that supports antioxidant-enzyme and inflammatory-resolution cofactor chemistry.
Supports: BRS3-FM1-PM1 BRS3-FM2-PM4 BRS3-FM3-PM8
Evidence-informed supplements used under selected physiological or clinical conditions — populated from KC Emerging Biological Supports when present.
Coming soon
Targeted dietary, fasting or timing protocols beyond ordinary healthy eating.
Coming soon
Practices that support circadian entrainment and biological timing.
Coming soon
Practices that deliberately influence autonomic function, adaptive stress responses and physiological resilience.
Coming soon
Maintain consistent daily meal timing to support lower inflammatory load and more stable antioxidant and resolution capacity over time.
Supports: BRS3-FM1-PM1 BRS3-FM2-PM3 BRS3-FM2-PM4 BRS3-FM3-PM7 BRS3-FM3-PM8
Prioritise sleep and manage stress load to help reduce systemic inflammatory pressure and support healthier immune and gut-related signalling.
Supports: BRS3-FM1-PM2 BRS3-FM2-PM4 BRS3-FM3-PM7
Reduce exposure to smoke, pollution, and excess alcohol to lower avoidable oxidative and inflammatory burden on the body's defence and repair systems.
Supports: BRS3-FM2-PM3 BRS3-FM2-PM4
Functional Mechanisms
Anti-inflammatory tone, antioxidant defence, and inflammation resolution set the background conditions under which neurotransmission, metabolism, and recovery operate. These mechanisms determine whether immune and oxidative load stays proportionate or becomes a persistent constraint on downstream function.
Maintains anti-inflammatory signalling tone by regulating cytokine activity, NF-κB-linked inflammatory drive, and gut-derived immune inputs.
FM page: BRS3(FM1) — Anti-Inflammatory Signalling Tone
Primary biological effects: ↓ NF-kB tone; ↓ pro-inflammatory cytokines; ↑ immune signalling balance
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Daily
Key constraints:
Connected mechanisms:
- BRS3-FM2-PM3 - Nrf2-Mediated Cellular Defence Regulation — Nrf2-Mediated Cellular Defence Regulation
- BRS3-FM2-PM4 - ROS Generation vs Clearance Balance — rOS Generation vs Clearance Balance
- BRS3-FM3-PM7 - Cytokine Network Modulation — cytokine Network Modulation
- BRS5-FM1-PM1 — Gut Barrier / Tight Junction Integrity — gut Barrier / Tight Junction Integrity
- BRS5(FM1) — Gut Barrier Integrity and Immune Interface — Upstream NF-κB transcriptional control
- BRS6-FM1-PM2 — Glycaemic Variability Regulation — Insulin Sensitivity & Glucose Disposal
- BRS3-FM2-PM3 — Nrf2-Mediated Cellular Defence Regulation
- BRS3-FM2-PM4 — ROS Generation vs Clearance Balance
- BRS3-FM2-PM5 — Lipid Peroxidation Control
- BRS3-FM2-PM6 — Antioxidant Network Recycling
Maintains antioxidant defense capacity by coordinating endogenous and dietary protection against redox overload and lipid peroxidation.
FM page: BRS3(FM2) — Antioxidant Defense Capacity
Primary biological effects: ↑ antioxidant enzyme induction; ↑ ROS buffering; ↓ oxidative damage
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Daily
Key constraints:
Connected mechanisms:
- BRS3-FM3-PM8 - Eicosanoid / SPM Balance — eicosanoid / SPM Balance
- BRS3(FM1) — Anti-Inflammatory Signalling Tone — anti-Inflammatory Signalling Tone
- BRS4-FM1-PM1 — Electron Transport Chain Function — electron Transport Chain Function
- BRS4-FM2-PM4 — ROS Production and Control — biological connection relevant to this mechanism
Maintains inflammation-resolution capacity through pro-resolving lipid mediator pathways that actively terminate inflammatory responses.
FM page: BRS3(FM3) — Inflammation Resolution Capacity
Primary biological effects: ↑ resolvins/protectins/maresins; ↑ debris clearance; ↓ unresolved inflammation
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: 48hours
Connected mechanisms:
- BRS1-FM3-PM7 — Neuronal Membrane DHA Incorporation — membrane long-chain PUFA substrate pools feeding specialized pro-resolving mediator formation
- BRS3-FM1-PM1 - NF-kB Signalling Regulation — nF-kB Signalling Regulation
- BRS3-FM1-PM2 - Gut-Derived Inflammatory Signalling — gut-Derived Inflammatory Signalling
- BRS3-FM2-PM5 - Lipid Peroxidation Control — lipid Peroxidation Control
- BRS5-FM1-PM2 — LPS / Endotoxin Containment — gut endotoxin containment upstream of systemic cytokine network tone
- BRS5(FM1) — Gut Barrier Integrity and Immune Interface — gut–immune interface context influencing inflammatory resolution substrate availability
- BRS6(FM1) — Glycaemic–Insulin Stability & Cognitive Energy Availability — post-prandial glycaemic context conditioning inflammatory cytokine expression
Cross-BRS Dependencies
Inflammatory and oxidative load never remains confined to immune biology. Cytokine tone, lipid peroxidation and impaired resolution reshape receptor environments, mitochondrial efficiency and neurotransmitter turnover — altering the conditions under which attention, mood and behavioural control are sustained. Strain that surfaces in connected regulatory biology often originates here, in immune tone and redox burden that never fully resolved.
Biological Contribution
Collectively, the Functional Mechanisms within BRS3 maintain the adaptive inflammatory and redox resilience required to preserve an immune environment that supports resilient neurotransmitter regulation within BRS1 during prolonged physiological demand.
Systems Significance
By preserving these immune-regulatory capacities, BRS3 functions as an upstream enabling system, reducing the likelihood that inflammatory and oxidative burden progressively constrain neurotransmitter regulation within BRS1 as allostatic load accumulates. Maintaining BRS3 therefore complements neurotransmitter precursor and cofactor biology by preserving the biological environment within which resilient neurotransmitter regulation can be sustained, rather than substituting for neurotransmitter regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS3 maintain proportionate inflammatory signalling, antioxidant defence, oxidative resilience and active inflammation resolution required to preserve immune and redox stability during prolonged physiological demand. Rather than acting through a single inflammatory pathway, these integrated capacities collectively regulate how immune and oxidative load influences the biological environment within which BRS1 sustains neurotransmitter regulation.
Supporting Evidence
Slavich & Irwin, 2014 — Established that psychological and physiological stressors activate inflammatory signalling capable of reshaping central nervous system function through coordinated immune, neuroendocrine and neurochemical pathways. This supports the framework interpretation that chronic inflammatory activation can become a principal upstream constraint on BRS1 performance during sustained physiological demand.
Savitz, 2020 — Demonstrated that immune activation reshapes neurotransmitter regulation through the kynurenine pathway and broader neuroimmune interactions, influencing both monoaminergic signalling and excitation–inhibition balance. This supports the BRAIN Framework interpretation that maintaining immune regulation preserves the biological environment required for resilient monoaminergic and excitation–inhibition regulation within BRS1.
Biological Contribution
Collectively, the Functional Mechanisms within BRS5 maintain adaptive gut barrier and microbial immune containment that enables BRS3 to sustain proportionate inflammatory tone under prolonged physiological demand.
Systems Significance
By preserving these gut–immune interface capacities, BRS5 functions as an upstream enabling system, reducing the likelihood that gut-derived immune signalling progressively amplifies systemic inflammatory burden within BRS3 as peripheral load accumulates. Maintaining BRS5 therefore complements direct immune-modulatory biology within BRS3 by preserving barrier containment rather than substituting for inflammatory regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS5 maintain gut barrier integrity, microbial ecological stability and gut-derived immune signalling containment required to limit inappropriate inflammatory spillover during prolonged physiological demand. Rather than acting through a single barrier mechanism, these integrated capacities collectively regulate how peripheral immune signals shape inflammatory tone within BRS3.
Supporting Evidence
O'Mahony et al., 2015 — Synthesised microbiota–gut–brain communication pathways linking gut ecology to peripheral and central inflammatory biology — supporting the framework interpretation that BRS5 gut–immune signalling shapes BRS3 inflammatory tone.
Slavich & Irwin, 2014 — Established stress-to-inflammation signalling as a systems-level pathway reshaping immune and neuroendocrine biology — supporting the interpretation that gut–immune perturbation can propagate inflammatory burden across BRS3 and connected systems.
Biological Contribution
Collectively, the Functional Mechanisms within BRS6 maintain adaptive stress–metabolic load allocation that enables BRS3 to sustain immune and redox regulation under prolonged physiological demand.
Systems Significance
By preserving neuroendocrine and autonomic regulatory capacity, BRS6 functions as the principal gateway through which neuroendocrine and metabolic resources are allocated across the integrated Biological Regulatory System network. This reduces the likelihood that chronic stress activation progressively constrains immune regulation within BRS3 as allostatic load accumulates. Maintaining BRS6 therefore complements direct immune-modulatory biology within BRS3 by preserving systemic stress containment rather than substituting for inflammatory regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS6 maintain HPA-axis rhythm, autonomic balance and metabolic load allocation required to regulate how stress mediators interact with inflammatory and oxidative biology during prolonged physiological demand. Rather than acting through a single stress hormone, these integrated capacities collectively shape the systemic conditions within which BRS3 sustains proportionate immune and redox regulation.
Supporting Evidence
McEwen, 2006 — Described bidirectional interactions between stress mediators, immune-inflammatory processes and cumulative regulatory burden — supporting the framework interpretation that BRS6 stress biology shapes BRS3 inflammatory load.
Slavich & Irwin, 2014 — Operationalised social and psychological stress as inflammatory signals reshaping neuroimmune biology — supporting the BRS6 → BRS3 pathway as a principal stress-to-inflammation bridge within the integrated BRS network.
Translational Examples
Kiecolt-Glaser et al., 2011 — Worked translational example: omega-3 supplementation reduced inflammatory cytokines (including IL-6) alongside anxiety symptoms in stressed adults. The principal inflammatory biology is measured and owned by BRS3-FM3-PM7; this dependency interprets how metabolic and neuroendocrine context (BRS6) may condition such inflammatory outcomes — without claiming this single study validates every intermediate step in the BRS6 → BRS3 pathway. Primary biology: BRS3-FM3-PM7 — Cytokine Network Modulation.
Specific Mechanisms
Specific Mechanisms (SMs) are interpretation layers — context-specific readings of stable BRS3 biology grounded in connected PMs, FMs, and KCs. They provide additional biological context for applying the BRAIN Framework. Current SM categories include SM-SNP (genetic variation), SM-CROSS (multi-BRS interpretive concepts), SM-Male and SM-Female (sex-specific biology), SM-Lifestage (e.g. childhood, pregnancy, older adulthood), and SM-Pattern (e.g. vegan, vegetarian, ketogenic). Functional phenotype interpretation is handled via the Phenome Registry rather than SM-PHEN pages. Individual SMs may be combined to create richer biological profiles and support future precision-nutrition applications.
References
[1] Chang et al. (2020). Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Higher hs-CRP and IL-6, with lower TNF-α, BDNF and bedtime salivary cortisol, in children and adolescents with ADHD (mixed marker pattern, not a uniform pro-inflammatory cytokine profile).
[2] Prehn-Kristensen et al. (2018). Reduced microbiome alpha diversity in young patients with ADHD. Reduced microbiome alpha diversity reported in ADHD.
[3] Bulut et al. (2007). Malondialdehyde levels in adult attention-deficit hyperactivity disorder. Significantly higher malondialdehyde in adult ADHD versus controls.
[4] Kurhan & Alp (2021). Dynamic Thiol/Disulfide Homeostasis and Oxidative DNA Damage in Adult Attention Deficit Hyperactivity Disorder. Thiol/disulfide homeostasis shifted toward oxidation and higher leukocyte 8-OHdG in adult ADHD.
[5] Miniksar et al. (2023). The Effect of Drug Use, Body Mass Index and Blood Pressure on Oxidative Stress Levels in Children and Adolescents with Attention Deficit and Hyperactivity Disorder. Elevated oxidative stress index and total oxidative status in children and adolescents with ADHD.
[6] Verlaet et al. (2018). Rationale for Dietary Antioxidant Treatment of ADHD. Narrative review framing a rationale for dietary antioxidant treatment of ADHD via immune, epigenetic, and oxidative-stress hypotheses.
[7] Verlaet et al. (2019). Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case–control comparison. Elevated glutathione in ADHD may reflect compensatory response to increased oxidative stress.
[8] Dufault et al. (2024). Nutritional epigenetics education improves diet and attitude of parents of children with autism or attention deficit/hyperactivity disorder. ADHD linked with metals contamination and ultra-processed foods, including colour-additive metals.
[9] Trebatická et al. (2006). Treatment of ADHD with French maritime pine bark extract, Pycnogenol®. A small randomized placebo-controlled trial found that Pycnogenol improved attention and reduced hyperactivity in children with ADHD. Companion studies from the same cohort reported normalization of total antioxidant status (TAS), improved glutathione balance, and reduced oxidative DNA damage, providing mechanistic support for oxidative stress pathways in ADHD. Replication remains limited.
[10] Dvořáková et al. (2006). The effect of polyphenolic extract from pine bark, Pycnogenol® on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). A small randomized placebo-controlled trial found that Pycnogenol improved attention and reduced hyperactivity in children with ADHD. Companion studies from the same cohort reported normalization of total antioxidant status (TAS), improved glutathione balance, and reduced oxidative DNA damage, providing mechanistic support for oxidative stress pathways in ADHD. Replication remains limited.
[11] Chovanová et al. (2006). Effect of polyphenolic extract, Pycnogenol®, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. A small randomized placebo-controlled trial found that Pycnogenol improved attention and reduced hyperactivity in children with ADHD. Companion studies from the same cohort reported normalization of total antioxidant status (TAS), improved glutathione balance, and reduced oxidative DNA damage, providing mechanistic support for oxidative stress pathways in ADHD. Replication remains limited.
[12] Slavich & Irwin (2014). From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Operationalised social and psychological stress as inflammatory signals reshaping neuroimmune biology — supporting the BRS6 → BRS3 pathway as a principal stress-to-inflammation bridge within the integrated BRS network.
[13] Savitz et al. (2020). The kynurenine pathway: a finger in every pie. Demonstrated that immune activation reshapes neurotransmitter regulation through the kynurenine pathway and broader neuroimmune interactions, influencing both monoaminergic signalling and excitation–inhibition balance. This supports the BRAIN Framework interpretation that maintaining immune regulation preserves the biological environment required for resilient monoaminergic and excitation–inhibition regulation within BRS1.
[14] O’Mahony et al. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Synthesised microbiota–gut–brain communication pathways linking gut ecology to peripheral and central inflammatory biology — supporting the framework interpretation that BRS5 gut–immune signalling shapes BRS3 inflammatory tone.
[15] McEwen et al. (2006). Protective and damaging effects of stress mediators in health and disease. Described bidirectional interactions between stress mediators, immune-inflammatory processes and cumulative regulatory burden — supporting the framework interpretation that BRS6 stress biology shapes BRS3 inflammatory load.
[16] Kiecolt-Glaser et al. (2011). Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Worked translational example: omega-3 supplementation reduced inflammatory cytokines (including IL-6) alongside anxiety symptoms in stressed adults. The principal inflammatory biology is measured and owned by BRS3-FM3-PM7; this dependency interprets how metabolic and neuroendocrine context (BRS6) may condition such inflammatory outcomes — without claiming this single study validates every intermediate step in the BRS6 → BRS3 pathway. Primary biology: BRS3-FM3-PM7 — Cytokine Network Modulation.